CROs: The Tip Of The Spear In Maximizing The Value of Hybrid, Virtual, And Synthetic Clinical Trials

Hybrid, virtual, and synthetic clinical trials are becoming a part of an increasing number of drug and biologics development programs. In this webinar, Rho experts discuss how their approach to maximizing the benefits of decentralized trials helps sponsors get the most out of their trials through offering solutions that bridge the gap across an ever-increasing number of data collection systems, leverage the information real-time, and bring this information to bear on business decisions, clinical trial execution decisions, and marketing application dossiers.